In Vitro–In Vivo Correlations (IVIVC) for Predicting the Clinical Performance of Metronidazole Topical Creams Intended for Local Action
The safety and efficacy of a generic medicine can be confirmed by demonstrating bioequivalence (BE) between the generic product and its reference listed drug (RLD) by measuring drug concentrations in the blood following administration. However, for topical dermatological products that are not absorb...
Main Authors: | Seeprarani Rath, Isadore Kanfer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/268 |
Similar Items
-
Utility of in vitro release testing (IVRT) to assess ‘sameness’ of 1% clotrimazole creams for use as a biowaiver
by: Hannah Wellington, et al.
Published: (2023-11-01) -
In vitro-in vivo correlation (IVIVC) of different parameters of dosage form
by: Shazia Ashraf, et al.
Published: (2021-07-01) -
In Vitro–In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone
by: Elena M. Tosca, et al.
Published: (2021-02-01) -
Establishment of Level a In Vitro–In Vivo Correlation (IVIVC) via Extended DoE-IVIVC Model: A Donepezil Case Study
by: Da Young Lee, et al.
Published: (2022-06-01) -
Long-Acting Injectable Antipsychotics—A Review on Formulation and In Vitro Dissolution
by: Magdalena Markowicz-Piasecka, et al.
Published: (2023-12-01)